ClinicalTrials.govpublic full text
Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis
multiple sclerosis, veterans, ms, cognitive assessment, ocrelizumab, ocr, modified fatigue impact scale (mfis), brief international cognitive assessment for ms (bicams), interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849206
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.